BeOne Medicines (ONC) Share-based Compensation Growth (3y) (2018 - 2026)
BeOne Medicines (ONC) Share-based Compensation Growth (3y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | -50.27% |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | -0.04% |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 38.45% |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Alnylam Pharmaceuticals | 36.08 Bn | 33.07 Bn | 959.66 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -50.27% |
| Dec 31, 2025 | 84.63% |
| Sep 30, 2025 | -69.92% |
| Jun 30, 2025 | 41.56% |
| Mar 31, 2025 | -37.95% |
| Dec 31, 2024 | -35.12% |
| Sep 30, 2024 | -68.21% |
| Jun 30, 2024 | -25.84% |
| Mar 31, 2024 | -73.65% |
| Dec 31, 2023 | 23.39% |
| Sep 30, 2023 | 24.05% |
| Jun 30, 2023 | 31.49% |
| Mar 31, 2023 | 25.34% |
| Dec 31, 2022 | 26.78% |
| Sep 30, 2022 | 28.53% |
| Jun 30, 2022 | 35.61% |
| Mar 31, 2022 | 35.43% |
| Dec 31, 2021 | 34.39% |
| Sep 30, 2021 | 38.71% |
| Jun 30, 2021 | 51.48% |